Patents-Review.com
ClassID:

97024 ⎘

C07K14/695 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin Corticotropin [ACTH]

Sub-classes:
Recent Application in this class:
#1
20240002433
2024-01-04

AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS

 #2
20220062387
2022-03-03

Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages

 #3
20220056099
2022-02-24

TEV protease variant, fusion protein thereof, preparation method therefor and use thereof

 #4
20190216901
2019-07-18

ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS

 #5
20190177362
2019-06-13

Amino diacids containing peptide modifiers

 #6
20190030134
2019-01-31

Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages

 #7
20170106053
2017-04-20

ACTH prophylactic treatment of renal disorders

 #8
20140336104
2014-11-13

ACTH prophylactic treatment of renal disorders

 #9
20140322821
2014-10-30

Molecule capable of binding to adrenocorticotropic hormone, and use thereof

 #10
20140288161
2014-09-25

Urocortin-III and uses thereof

 #11
20140004603
2014-01-02

Urocortin-III and uses thereof

 #12
20120309696
2012-12-06

Methods of treating overproduction of cortisol using ACTH antagonist peptides

 #13
20120270792
2012-10-25

Urocortin-III and uses thereof

 #14
20110312878
2011-12-22

PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS

 #15
20110112175
2011-05-12

Peptide biosynthesis and pain therapy

 #16
20110112174
2011-05-12

Peptide biosynthesis and pain therapy

 #17
20100260681
2010-10-14

ADRENOCORTICOTROPIC HORMONE ANALOGS AND RELATED METHODS

 #18
20090232838
2009-09-17

Ligands of melanocortin receptors

 #19
20090156493
2009-06-18

Urocortin-III and uses thereof

 #20
20080234467
2008-09-25

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #21
20080227954
2008-09-18

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #22
20080207518
2008-08-28

Adrenocorticotropic hormone analogs and related methods

 #23
20080139785
2008-06-12

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #24
20080032931
2008-02-07

ACTIVATABLE CLOSTRIDIAL TOXINS

 #25
20080032930
2008-02-07

Activatable clostridial toxins

 #26
20080015152
2008-01-17

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #27
20070293418
2007-12-20

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #28
20070197774
2007-08-23

Adrenocorticotropic hormone analogs and related methods

 #29
20070077617
2007-04-05

Polypeptide cleavage method using OmpT protease variant

 #30
20060281070
2006-12-14

Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy

 #31
20060128620
2006-06-15

Adrenocorticotropic hormone analogs and related methods

 #32
20060063699
2006-03-23

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #33
20060003937
2006-01-05

Urocortin-III and uses thereof